Student Name Capella University PSYC FPX 4310 Biological Psychology Prof. Name Date PSYC FPX 4310 Assessment 4 Study Applications MDMA (3,4-methylenedioxymethamphetamine), commonly called ecstasy or molly, primarily affects the brain by increasing the activity and release of serotonin, while also influencing dopamine and norepinephrine. These neurotransmitter changes help explain MDMA’s short-term effects on mood, sociability, arousal, and emotional experiences. Repeated or high-dose use, however, has been associated with concerns involving cognition, serotonin function, temperature regulation, psychological health, and other physiological systems. The effects vary depending on factors such as dose, frequency of use, individual biology, environmental conditions, and use of other substances. Literature Review MDMA has been extensively studied across neuroscience, psychology, pharmacology, toxicology, and behavioral health. Researchers have investigated how the drug changes neurotransmitter activity, affects brain function, influences cognition and behavior, and contributes to potential neurological and physiological complications. A literature review of MDMA’s neurobiology requires evidence from multiple research perspectives. Peer-reviewed studies available through resources such as PubMed, PsycINFO, ScienceDirect, and university research databases provide information about serotonin activity, neurotoxicity, cognitive effects, psychological mechanisms, and substance-use behaviors. Research in these areas helps explain not only what happens in the brain after MDMA exposure but also why repeated use may contribute to psychological and behavioral problems. How MDMA Affects the Brain MDMA produces its primary effects by substantially altering several neurotransmitter systems. Serotonin is particularly important because it contributes to mood, emotional regulation, cognition, social behavior, and other neurological processes. MDMA promotes the release of serotonin and interferes with normal serotonin transport. It also increases dopamine and norepinephrine activity. Together, these changes contribute to the characteristic effects associated with the drug, including increased energy, elevated mood, emotional closeness, and heightened sociability. The same neurological mechanisms responsible for MDMA’s desired effects can also create physiological and psychological risks. Large or repeated changes in neurotransmitter activity may interfere with normal brain functioning and contribute to adverse effects. Neurotransmitters Involved in MDMA Use Serotonin Serotonin is the neurotransmitter most strongly associated with MDMA’s effects. It plays an important role in mood, sleep, appetite, cognition, emotional regulation, and social behavior. The rapid increase in serotonin activity following MDMA exposure helps explain why users may experience euphoria, emotional openness, and increased feelings of social connection. Following substantial serotonin release, however, the brain may temporarily have reduced availability of the neurotransmitter. Repeated exposure has therefore generated research interest in possible changes to serotonergic functioning. Dopamine and Norepinephrine MDMA also affects dopamine and norepinephrine. Dopamine contributes to reward, motivation, and reinforcement, while norepinephrine is involved in alertness, arousal, cardiovascular activity, and the body’s stress response. Changes in these systems can contribute to increased energy and alertness but may also place additional demands on the cardiovascular and physiological systems. Because MDMA affects several neurotransmitters simultaneously, its effects cannot be explained through serotonin alone. Cognitive and Behavioral Effects of MDMA Cognitive functioning is another major area of MDMA research. Studies have investigated possible associations between MDMA exposure and changes in memory, attention, learning, and decision-making. The evidence is complicated by differences among study participants. People who use MDMA may also use cannabis, alcohol, stimulants, or other substances, making it difficult to determine whether a particular cognitive effect is caused exclusively by MDMA. Other variables may include: Consequently, research findings should be interpreted carefully rather than assuming that every person who uses MDMA will experience the same cognitive effects. Potential Neurotoxicity of MDMA What Is Neurotoxicity? Neurotoxicity refers to harmful changes that affect neurons or the functioning of the nervous system. One important concern associated with MDMA research is whether repeated or high-dose exposure can produce lasting changes in serotonergic systems. Animal research has provided evidence of changes involving serotonin-containing neurons and serotonin transport mechanisms. Human studies have also examined brain function and serotonergic activity using different neurological and neuroimaging approaches. However, the evidence is not completely uniform. Differences in study methods, drug exposure patterns, individual characteristics, and the use of other substances can influence results. For this reason, claims about permanent neurological damage in humans should be presented cautiously. Current evidence supports concern about potential neurological effects while also demonstrating the need for additional long-term human research. Strengths and Limitations of MDMA Research Research into MDMA’s neurobiology has several important strengths. Scientists have used animal models, human observational studies, neuroimaging, biochemical testing, and behavioral assessments to investigate different aspects of MDMA exposure. Animal studies can help researchers examine neurological mechanisms that cannot be directly investigated in humans. Human research, in contrast, provides information about real-world cognitive, behavioral, and psychological outcomes. Another strength is the interdisciplinary nature of the literature. Neuroscience, psychology, pharmacology, psychiatry, toxicology, and public health research all contribute to understanding MDMA. Limitations of Existing Evidence Despite these strengths, several limitations affect interpretation of the research. Some studies focus on short-term exposure rather than long-term outcomes. Other research may be affected by polysubstance use or differences in participants’ mental health histories. Individual biological differences also make it difficult to predict the effects of MDMA on a specific person. Factors such as genetics, dose, frequency of use, hydration, temperature, physical activity, and other substances can influence outcomes. Longitudinal human studies are therefore important for determining the long-term neurological and psychological effects of repeated MDMA exposure. MDMA, Serotonin Syndrome, and Environmental Risks MDMA can produce serious physiological complications, particularly when serotonergic activity becomes excessive or when the drug is used in stressful environmental conditions. Serotonin syndrome is a potentially serious condition associated with excessive serotonin activity. Symptoms can include agitation, confusion, tremors, increased body temperature, muscle abnormalities, and changes in neurological functioning. The risk may increase when MDMA is combined with other substances or medications that affect serotonin. Why Temperature Matters During MDMA Use MDMA can influence the body’s ability to regulate temperature. Hot environments, crowded spaces, prolonged dancing, and intense physical activity can increase physiological stress. Elevated body temperature can become dangerous, particularly when combined with changes in hydration and cardiovascular function. These environmental factors are therefore important when evaluating the potential health consequences of MDMA.

Student Name Capella University PSYC FPX 4310 Biological Psychology Prof. Name Date Literature Review The neurobiology of MDMA (3,4-methylenedioxymethamphetamine), commonly known as ecstasy or molly, involves complex changes in brain chemistry, particularly in serotonin, dopamine, and norepinephrine systems. Research suggests that repeated or heavy MDMA use may affect cognitive function, mood, behavior, and neurological health, although the severity and duration of these effects vary among individuals. Understanding how MDMA affects the brain is important for evaluating substance-use risks and developing appropriate prevention and treatment strategies. For this literature review, peer-reviewed research was examined to explore the biological and psychological mechanisms associated with MDMA abuse. The literature was identified through established academic databases and research resources, including PubMed, ScienceDirect, PsycINFO, and the Capella University Library. These databases provide access to peer-reviewed studies in psychology, neuroscience, pharmacology, and health sciences. The search focused on research addressing MDMA neurobiology, serotonin and neurotransmitter activity, cognitive effects, neurotoxicity, psychological theories of substance use, and potential health consequences. This approach provides multiple perspectives for understanding how MDMA affects the brain and behavior. Scholarly Research Findings MDMA produces its characteristic psychological and physiological effects primarily by influencing neurotransmitter systems in the brain. The drug increases the release of serotonin, dopamine, and norepinephrine. Serotonin is particularly important because it contributes to mood, emotional regulation, cognition, and social behavior. The substantial increase in serotonin activity associated with MDMA use may explain some of its short-term effects, including elevated mood, increased sociability, and feelings of emotional closeness. At the same time, changes in neurotransmitter activity can have negative consequences. Research has associated MDMA exposure with alterations in memory, attention, decision-making, and other cognitive processes. The effects may depend on factors such as dosage, frequency of use, individual biological differences, and exposure to other substances or environmental stressors. PSYC FPX 4310 Assessment 3 Literature Review Lin et al. (2013) examined the effects of MDMA on brain function and reported evidence of oxidative stress and neurological effects following MDMA exposure. Their findings contribute to concerns about the biological consequences of repeated MDMA use and demonstrate why the relationship between MDMA exposure and neurological health requires continued investigation. Research has also examined MDMA’s effects on serotonin neurons. Mercer et al. (2017) investigated MDMA-related changes involving serotonin transporter binding and serotonin activity in the brain. Their findings contribute to the broader body of evidence suggesting that MDMA can produce significant changes in serotonergic functioning. Because serotonin is involved in mood and cognitive processes, disruption of this system may have implications for emotional and behavioral health. Neurotransmitters and Brain Function The neurobiology of MDMA is closely associated with changes in several neurotransmitter systems. Serotonin is the primary neurotransmitter affected, although dopamine and norepinephrine are also involved. These chemical systems interact to influence mood, arousal, attention, reward, and behavior. The immediate increase in serotonin can contribute to the pleasurable and socially enhancing effects that make MDMA appealing to some users. However, repeated exposure may interfere with normal serotonergic functioning. Müller and Homberg (2015) emphasized the important role of serotonin in drug use and addiction, highlighting how changes in serotonergic systems can influence substance-related behaviors. MDMA may also affect the body’s stress-response system. Changes involving the hypothalamic-pituitary-adrenal (HPA) axis may contribute to physiological and psychological stress responses associated with MDMA exposure. These effects demonstrate that MDMA does not act on one isolated brain pathway but instead influences interconnected neurological and physiological systems. Cognitive and Behavioral Effects of MDMA Cognitive functioning is another important area of concern. Research has associated MDMA exposure with changes in memory, attention, learning, and decision-making. These effects are particularly relevant when MDMA is used repeatedly or in high doses. The relationship between MDMA use and cognitive performance is complex because research findings may be influenced by factors such as polysubstance use, pre-existing psychological conditions, dosage, and differences in individual vulnerability. Nevertheless, evidence concerning changes in memory and other cognitive processes supports continued research into the long-term effects of MDMA. Potential Neurotoxicity One of the major concerns identified in the literature is the possibility of serotonin-related neurotoxicity. Neurotoxicity refers to damage or adverse changes affecting nervous-system cells or their functioning. Research involving MDMA has investigated changes in serotonin transporters, serotonin-containing neurons, and related neurological processes. Spillane et al. (2013) described MDMA as a substance capable of producing complex effects on neurotransmitter systems and brain function. The literature suggests that MDMA can produce both acute and potentially longer-lasting neurological changes, although the extent and clinical significance of these effects remain subjects of scientific investigation. The evidence also indicates that animal studies, human studies, and neuroimaging research can produce different perspectives on MDMA-related neurological changes. Therefore, conclusions about permanent neurological damage in humans should be made cautiously and should account for differences in study design and patterns of drug exposure. Strengths and Weaknesses of Existing Research Existing research provides valuable evidence about the neurobiology of MDMA because scientists have used several research methods. Animal models allow researchers to examine neurological mechanisms that cannot be studied directly in humans. Human studies provide information about behavioral and cognitive outcomes, while neuroimaging and biochemical research can help identify changes in brain activity and neurotransmitter systems. Another strength is the interdisciplinary nature of MDMA research. Studies have been conducted across neuroscience, psychology, pharmacology, toxicology, and psychiatry. Combining these perspectives provides a more complete understanding of how MDMA can affect both brain function and behavior. However, several limitations should be considered. Some studies focus primarily on acute effects rather than long-term consequences. Other studies may be affected by confounding variables, including the use of other substances, differences in dosage, environmental conditions, and pre-existing mental health conditions. Individual differences also make it difficult to predict how a particular person will respond to MDMA. Genetic factors, brain chemistry, frequency of use, dose, hydration, temperature, and physical activity may influence outcomes. Consequently, additional longitudinal research is needed to clarify the long-term neurological and psychological consequences of repeated MDMA exposure. Serotonin Syndrome and Environmental Factors MDMA can also produce serious physiological complications, particularly when

Student Name Capella University PSYC FPX 4310 Biological Psychology Prof. Name Date Theories and Ethics in the Neurobiology of MDMA Abuse MDMA, commonly known as ecstasy, affects several neurotransmitter systems in the brain, particularly serotonin, dopamine, and norepinephrine. Research on the neurobiology of MDMA abuse helps explain how the drug influences mood, cognition, behavior, and neurological functioning. Although MDMA is associated with recreational misuse and potential health risks, researchers have also investigated its controlled therapeutic use, particularly as an adjunct to psychotherapy for post-traumatic stress disorder (PTSD). Examining different psychological and neurobiological theories provides a broader understanding of both the risks associated with MDMA abuse and its potential clinical applications. MDMA, or 3,4-methylenedioxymethamphetamine, is a psychoactive substance commonly used recreationally because it can produce euphoria, increased sociability, emotional closeness, and heightened sensory experiences. However, its effects on neurotransmitters and brain systems have raised important questions about cognitive functioning, neurotoxicity, addiction, and serotonin-related complications. Theories Used to Understand MDMA Several theories can be used to examine the biological and psychological effects of MDMA. These theories provide different perspectives on how MDMA affects the brain and why repeated or high-risk use may contribute to neurological and behavioral problems. MDMA and PTSD Treatment Sessa (2017) examined the potential therapeutic use of MDMA for PTSD. The central idea is that MDMA may be useful as an adjunct to psychotherapy when administered in a carefully controlled clinical environment. Rather than treating PTSD through MDMA alone, the proposed approach combines the substance with specialized psychotherapy and professional monitoring. Clinical research has suggested that MDMA may temporarily influence emotional processing, fear responses, and interpersonal connection. These effects could potentially help some individuals engage with traumatic memories during psychotherapy. However, therapeutic administration is substantially different from recreational use because clinical studies involve controlled doses, screening, monitoring, and trained professionals. The evidence discussed by Sessa (2017) also has limitations. Early studies often involved relatively small samples, meaning that additional research is necessary to establish the effectiveness and safety of MDMA-assisted psychotherapy across larger and more diverse populations. Reward Deficiency Syndrome and Addiction The Reward Deficiency Syndrome (RDS) model provides another framework for understanding substance misuse. Blum et al. (2021) describe addiction as involving alterations in brain reward and motivational systems. From this perspective, repeated substance use can influence the neural pathways associated with reward, reinforcement, and motivation. Applied to MDMA abuse, the RDS framework can help researchers examine why some individuals may continue using psychoactive substances despite experiencing negative consequences. It also emphasizes that addiction is influenced by complex biological and behavioral mechanisms rather than simply being a matter of personal choice. This perspective is particularly relevant when studying repeated MDMA exposure because changes in reward-related systems may interact with environmental, psychological, and biological factors. Serotonin Depletion and Cognitive Effects The serotonin depletion hypothesis is another important concept in the study of MDMA. MDMA produces significant effects on the brain’s serotonergic system by increasing the availability of serotonin. After MDMA exposure, serotonin function may be disrupted, particularly with repeated or heavy use. Serotonin is involved in mood regulation and several cognitive processes, including attention, learning, and memory. Consequently, researchers have investigated whether repeated MDMA exposure is associated with changes in cognitive performance. Research examining human MDMA use has reported possible neurological and cognitive alterations, although findings can vary depending on factors such as dosage, frequency of use, other substances used, and individual characteristics (Montgomery & Roberts, 2022). How the Theories Apply to MDMA Research The theories discussed above can be applied to different aspects of MDMA research, including addiction, cognition, neurotoxicity, serotonin functioning, and potential therapeutic applications. Sessa (2017) suggests that MDMA administered under controlled clinical conditions may have therapeutic value for individuals with PTSD. This research is important because it demonstrates that the effects of a substance can differ substantially depending on the dose, setting, purpose, and level of medical supervision. In contrast, recreational MDMA use may involve unpredictable doses, adulterated substances, repeated exposure, and combinations with other drugs. Therefore, findings from controlled clinical trials should not automatically be generalized to recreational use. MDMA Interactions With Other Drugs MDMA can interact with pharmaceutical medications and other recreational substances. Papaseit et al. (2020) reviewed evidence concerning MDMA-drug interactions and highlighted the possibility of serious adverse effects. These interactions can involve both pharmacokinetic and pharmacodynamic mechanisms. Pharmacokinetic interactions affect how the body absorbs, distributes, metabolizes, or eliminates a substance, whereas pharmacodynamic interactions involve changes in how substances affect physiological systems. The potential consequences of MDMA-drug interactions are particularly important because combinations involving serotonergic substances may increase the risk of serious complications, including serotonin toxicity. The risk may also be influenced by individual characteristics such as genetics, biological sex, and other physiological factors. Research therefore supports caution regarding MDMA use alongside other substances. The possibility of unpredictable interactions is one reason recreational MDMA use can carry significant health risks. Neurotoxicity and MDMA Neurotoxicity is another important area of research concerning MDMA abuse. Costa and Gołembiowska (2022) reviewed mechanisms associated with MDMA-related neurotoxicity and described several biological processes that may contribute to neurological effects. Repeated or high-dose exposure may place stress on neurological systems. Researchers have examined factors such as oxidative stress, mitochondrial dysfunction, changes in neurotransmitter systems, and other cellular mechanisms when evaluating potential neurotoxic effects. However, the evidence must be interpreted carefully. Human research can be affected by confounding variables because people who use MDMA recreationally may also consume alcohol, cannabis, stimulants, or other substances. Differences in dose and frequency of use can further complicate conclusions. Environmental Factors and Serotonin Syndrome Environmental conditions may also influence the severity of MDMA-related complications. Tao et al. (2017) examined how environmental factors may affect serotonin syndrome associated with ecstasy abuse. Serotonin syndrome can occur when excessive serotonergic activity affects the nervous system. Its severity may vary from relatively mild symptoms to potentially life-threatening complications. MDMA’s effects on serotonin and other neurotransmitter systems are particularly relevant to this condition. The research discussed by Tao et al. (2017) suggests that environmental factors can influence

Student Name Capella University PSYC FPX 4310 Biological Psychology Prof. Name Date PSYC FPX 4310 Assessment 1 Neurobiology of Alcohol Abuse MDMA, commonly known as ecstasy or 3,4-methylenedioxymethamphetamine, affects several neurotransmitter systems in the brain, particularly serotonin, dopamine, and norepinephrine. Its effects can produce euphoria, increased emotional warmth, heightened sociability, and changes in sensory perception. At the same time, repeated or excessive MDMA use has been associated with adverse neurological, cognitive, psychological, and physiological effects. Research also suggests that MDMA may have therapeutic applications, particularly when administered in controlled clinical settings for conditions such as post-traumatic stress disorder (PTSD). Understanding the neurobiology of MDMA abuse is therefore important for distinguishing potential therapeutic applications from the risks associated with recreational misuse. This assessment examines peer-reviewed literature concerning the neurobiology of MDMA abuse. The selected articles address MDMA’s effects on neurotransmitters, neurological and cognitive functioning, potential neurotoxicity, serotonin syndrome, and emerging therapeutic applications. Neurobiology of MDMA MDMA is a psychoactive substance that primarily affects the brain’s serotonergic system. It increases the availability of serotonin by promoting its release and interfering with normal serotonin reuptake. Serotonin plays an important role in regulating mood, emotions, sleep, appetite, and social behavior. Changes in serotonin signaling contribute to many of the subjective effects associated with MDMA use. MDMA also influences dopamine and norepinephrine systems. These neurotransmitters contribute to reward, motivation, alertness, arousal, and cardiovascular responses. The combined effects of these neurotransmitter systems help explain why MDMA can produce feelings of pleasure, emotional closeness, increased energy, and heightened sociability. However, the same neurochemical activity that produces the desired effects can contribute to harmful outcomes. High doses, frequent use, environmental stressors, and interactions with other substances may increase the risk of hyperthermia, cardiovascular complications, serotonin syndrome, psychological distress, and neurological harm. Health Effects Associated With MDMA Abuse The effects of MDMA can vary according to dosage, frequency of use, individual characteristics, and environmental conditions. Acute effects may include increased heart rate, elevated body temperature, changes in blood pressure, anxiety, and altered perception. Longer-term or repeated use has been investigated in relation to cognitive and neurological changes. Researchers have examined possible effects on memory, attention, executive functioning, and serotonin-related brain processes. However, determining the long-term effects of MDMA in humans is challenging because studies may be affected by factors such as polydrug use, differences in dosage, frequency of use, and individual health characteristics. Search Strategies for the Literature Review The literature search focused on identifying peer-reviewed research addressing the neurobiology, neurological effects, toxicity, and potential therapeutic applications of MDMA. Search terms included “MDMA,” “ecstasy,” “3,4-methylenedioxymethamphetamine,” “neurobiology,” “brain,” “serotonin,” “dopamine,” “norepinephrine,” “neurotransmitter,” “reward,” “arousal,” “dependence,” “toxicity,” “cognitive effects,” “mental health,” “prevention,” and “treatment.” Research was conducted using academic resources such as the Capella University Library, PubMed, Google Scholar, and the National Library of Medicine. Boolean operators were used to combine keywords and narrow the search results. Priority was given to peer-reviewed articles, literature reviews, clinical research, and research conducted by subject-matter experts. The search strategy helped identify research addressing both the potential risks and possible therapeutic applications of MDMA. Particular attention was given to studies examining neurological effects, serotonin activity, neurotoxicity, cognitive changes, and clinical applications. Analysis of Selected Articles Article 1: MDMA and PTSD Treatment Sessa (2017) examined the potential use of MDMA as an adjunct to psychotherapy for individuals experiencing PTSD. The article reviews clinical and neurophysiological evidence concerning MDMA-assisted treatment and discusses how the drug may influence emotional processing during psychotherapy. The research describes findings from early clinical studies and phase-based research investigating MDMA-assisted psychotherapy. These studies suggest that MDMA may help some individuals engage with traumatic memories while experiencing reduced fear and increased feelings of trust and emotional safety. An important distinction is that therapeutic MDMA administration differs substantially from recreational use. Clinical treatment involves controlled doses, screening, professional supervision, and structured psychotherapy. Recreational use generally lacks these safeguards and may involve unpredictable doses or additional substances. Sessa (2017) also identifies the need for additional research because early clinical studies often involved relatively small samples. Larger and well-controlled studies are necessary to establish the safety, effectiveness, and long-term outcomes of MDMA-assisted treatment. Article 2: Human Psychobiology of MDMA Parrott (2013) provides an extensive review of empirical research concerning the human psychobiology of MDMA. The article examines evidence accumulated over several decades and considers both the psychological effects and potential health risks associated with MDMA use. The review addresses MDMA’s interactions with other drugs and substances, which are particularly important because recreational users may combine MDMA with alcohol, prescription medications, or other psychoactive substances. These combinations may alter MDMA’s effects and potentially increase health risks. Parrott’s analysis also highlights the importance of considering individual differences when evaluating MDMA-related outcomes. Factors such as dose, frequency of use, environmental conditions, and the use of other substances can affect an individual’s response. The article contributes to the understanding of MDMA by demonstrating that its effects cannot be explained by a single neurotransmitter or biological mechanism. Instead, MDMA affects multiple neurochemical systems and interacts with psychological and environmental factors. Article 3: Neurotoxicity of MDMA Costa and Gołembiowska (2022) review the mechanisms that may contribute to MDMA-related neurotoxicity. Their research examines how MDMA affects the central nervous system and identifies several biological processes that may contribute to neurological injury. The review focuses on mechanisms involving serotonin and dopamine transporters, oxidative stress, excitotoxicity, and neuroinflammation. These processes may become particularly important when MDMA is used at high doses or repeatedly. The authors emphasize that the effects of MDMA depend on factors such as dose, frequency, and duration of exposure. This is important because occasional exposure and repeated high-dose exposure may not produce identical biological outcomes. The findings also demonstrate why continued research is necessary. Understanding the mechanisms underlying MDMA-related neurotoxicity may help researchers develop more effective prevention strategies and identify potential interventions for individuals experiencing adverse effects. Article 4: Environmental Factors and Serotonin Syndrome Shokry and Callanan (2017) examine environmental factors that may influence serotonin syndrome associated with ecstasy use. Serotonin syndrome